• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Clinical Medicine >The utility of a local multidisciplinary working group to oversee the establishment of rapidly evolving standards of care and to support trial recruitment during the COVID-19 pandemic
【2h】

The utility of a local multidisciplinary working group to oversee the establishment of rapidly evolving standards of care and to support trial recruitment during the COVID-19 pandemic

机译：当地多学科工作组的效用监督建立迅速不断发展的护理标准并在Covid-19大流行期间支持审判招聘

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Coronavirus disease 2019 (COVID-19) was first identified in December 2019 in Wuhan, China. The first analyses of cases described high numbers of critically ill patients requiring intensive care admission with significant late inflammatory features. By the time the first cases of SARS-CoV-2 infection were diagnosed in the UK, a wide range of drugs were under consideration and it became clear that the input of clinicians covering all organ systems (in particular, infectious diseases, haematology, rheumatology, renal medicine and intensive care) and of expert specialist pharmacists was necessary at the local level. Thus, an expert multidisciplinary (MDT) group within our organisation was convened to offer a standardised approach and robust clinical governance for the treatment of COVID-19 patients admitted to our hospitals and rapidly develop standards of care as evidence evolved. This commentary explores the methods and mechanisms for creating an MDT COVID-19 treatment working group which are applicable to any hospital likely to admit and care for high numbers of COVID-19 patients and demonstrates how the structure and governance of the group allowed for rapid adoption of both dexamethasone and tocilizumab into standard of care as data became available.
机译：2019年12月（Covid-19）首次于2019年12月在中国武汉确定了冠状病毒疾病。第一次分析案件描述了，需要密集护理患者的患者大量，具有重要的晚期炎症特征。当英国诊断患者的第一次SARS-COV-2感染病例时，正在考虑广泛的药物，并明确表示涵盖所有器官系统的临床医生（特别是传染病，血液学，风湿病学）的投入，肾脏医学和重症监护权，专家专家药剂师在地方一级是必要的。因此，召开组织内的专家多学科（MDT）集团为提供标准化的方法，并为录取医院的Covid-19患者的治疗提供了标准化的方法和强大的临床治理，并随着证据进化的证据迅速发展护理标准。该评论探讨了创建MDT Covid-19治疗工作组的方法和机制，适用于可能承认和关心高量Covid-19患者的任何医院，并展示了本集团的结构和治理如何快速采用作为数据可用的地塞米松和康斯康纳布标准的护理标准。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号